Atypical femur fracture in a male without history of bisphosphonate use: a case report

被引:0
|
作者
Al-Ajlouni, Yazan A. [1 ]
Lee, Justin Lin [1 ]
Lee, Jessica Lin [1 ]
Samuels, Blossom [1 ,2 ]
机构
[1] New York Med Coll, Sch Med, Valhalla, NY 10595 USA
[2] Westchester Med Ctr, Valhalla, NY 10595 USA
关键词
Atypical femur fractures; Bisphosphonate-naive; Male; Teriparatide; Surgical management; FEMORAL FRACTURES; TERIPARATIDE; RISK;
D O I
10.1186/s13256-023-04308-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAtypical femur fractures are a rare occurrence, especially in bisphosphonate-naive men, and merit reporting owing to their unusual presentation and clinical implications. This case report highlights a unique instance of atypical femur fractures in a 73-year-old male with no prior bisphosphonate exposure.Case presentationThe patient, a 73-year-old Indian male with no history of bisphosphonate use, presented with left thigh pain and swelling following a minor fall. Radiographic assessment unveiled a closed left mid diaphyseal femoral shaft fracture. Subsequent imaging revealed an impending fracture in the contralateral femur. A comprehensive diagnostic evaluation, encompassing radiographic analysis, laboratory tests, and clinical assessment confirmed the diagnosis. Surgical management via intramedullary nailing was pursued for both fractures. Notably, the patient's medical history was characterized by radiographic manifestations, the infrequent occurrence of atypical femur fractures in men, and associated risk factors. Treatment encompassed anabolic bone therapy employing teriparatide, alongside discontinuation of antiresorptive agents.ConclusionsThis case underscores the significance of considering atypical femur fractures in older individuals with limited trauma history. It accentuates the role of anabolic agents in the therapeutic regimen and contributes to the evolving understanding of atypical femur fractures. The report underscores the need for vigilant monitoring and tailored management strategies in similar cases, thereby enhancing clinical practice and patient care.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Atypical femur fracture in a male without history of bisphosphonate use: a case report
    Yazan A. Al-Ajlouni
    Justin Lin Lee
    Jessica Lin Lee
    Blossom Samuels
    Journal of Medical Case Reports, 18
  • [2] Atypical Femur Fracture: A Rare Complication of Bisphosphonate Use
    Lorgunpai, S. J.
    Growdon, M.
    Berry, S. D.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S193 - S193
  • [3] A Case Report of Long-Term Bisphosphonate Therapy and Atypical Stress Fracture of Bilateral Femur
    Jo, Yil Ryun
    Kim, Hye Won
    Moon, Seock Ho
    Ko, Young Jin
    ANNALS OF REHABILITATION MEDICINE-ARM, 2013, 37 (03): : 430 - 432
  • [4] Atypical femur fracture during bisphosphonate drug holiday: a case series
    A. J. Lovy
    S. M. Koehler
    A. Keswani
    D. Joseph
    R. Hasija
    R. Ghillani
    Osteoporosis International, 2015, 26 : 1755 - 1758
  • [5] Atypical femur fracture during bisphosphonate drug holiday: a case series
    Lovy, A. J.
    Koehler, S. M.
    Keswani, A.
    Joseph, D.
    Hasija, R.
    Ghillani, R.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (06) : 1755 - 1758
  • [7] Bisphosphonate use and atypical femur fractures
    Carol Wilson
    Nature Reviews Endocrinology, 2010, 6 (8) : 420 - 420
  • [8] Bisphosphonate-Associated Atypical Subtrochanteric Femur Fracture
    Wolin, Ely A.
    Banks, Kevin P.
    Vroman, Penny J.
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2015, 43 (01) : 72 - 73
  • [9] Atypical femur fracture following romosozumab and bisphosphonate treatment
    Jacunski, Mark
    Johnsson, Hanna
    Ralston, Stuart H.
    Hauser, Barbara
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2025, 55 (01): : 19 - 22
  • [10] Teriparatide Prevented Near Atypical Femur Fracture by Reducing Cortical Thickening in a Symptomatic Patient With Prolonged Use of Oral Bisphosphonate: A Case Report
    Kaur, Jaspinder
    Chavez, Luis
    Sachmechi, Issac
    Kim, Paul
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2016, 6 (06) : 183 - 186